The Lancet infectious diseases
The most recent articles from:
Lancet Infect Dis
-
It is a widespread misconception that tiered pricing of vaccines entails the producers or consumers in the high-price markets subsidising the consumers in the low-price markets. Such a view is inconsistent with realities, as well as with economic theory. ⋯ The producers benefit from increased revenues and profits, and the developed countries' high-price market consumers benefit from slightly lower prices than would be the case in the absence of the low-price market. This article rebuts the notion that tiered pricing of vaccines is a subsidy, and discusses past experiences, present challenges, and future opportunities for tiered pricing of vaccines in relation to developing countries' immunisation programmes.